Skip to main content
Minoxidil comes in two very different forms, and the difference matters. The liquid or foam rubbed into the scalp is a properly authorised medicine for male pattern hair loss in EU countries, sold both on prescription and over the counter — and it is the form the hair-loss evidence on this page is based on.

​
What is topical minoxidil?

Topical minoxidil is a route of administration, not a brand: it means minoxidil applied to the scalp rather than taken as a tablet. It has been authorised for use in the EU since 1 May 1988. The Spanish medicines agency lists it under many names — Regaine, Lacovin, Alopexy, Regaxidil, Aloxidil, Alocutan, Minoxidil Biorga, Normopil and others — all supplied without a prescription. The 5% strength carries a warning against use in women because of the risk of unwanted hair growth elsewhere on the body, so the 2% strength is the one used in women.
Active ingredient: minoxidil. Dosages: 5% topical · 2.5–5 mg oral (oral is off-label for hair loss — see below).

​
How it works

Applied to the scalp, minoxidil opens ATP-sensitive potassium channels, widens small blood vessels and appears to keep hair follicles in their growing (anagen) phase for longer and increases hair diameter — although exactly how it acts on hair is still not fully understood. Topical minoxidil combines well with finasteride or dutasteride.

​
What the studies reported

The pivotal trial (Olsen et al., J Am Acad Dermatol 2002;47(3):377-385, PMID 12196747) ran for 48 weeks in men aged 18–49 with vertex-pattern loss, so it does not establish results beyond one year or in other patterns of hair loss. A separate review (Rodrigues Dias et al., Front Pharmacol 2026;16:1718208) reproduces the Olsen 2002 hair-count figures and states that oral minoxidil is not formally approved for androgenetic alopecia.
In a 24-week randomised trial of oral minoxidil 5 mg versus topical minoxidil 5% (n=45 per arm; Penha et al., JAMA Dermatol 2024;160(6):600-605, PMID 38598226): hypertrichosis occurred in 22/45 (49%) on oral versus 11/45 (25%) on topical (P=.02); headache in 6/45 (14%) versus 1/45 (2%) (P=.046); scalp eczema was more frequent with topical, 7/45 (16%) versus 1/45 (2%).A separate retrospective multicentre study of 1,404 patients treated for at least 3 months (Vano-Galvan et al., J Am Acad Dermatol 2021;84(6):1644-1651, PMID 33639244) found the most frequent adverse effect was hypertrichosis (15.1%, causing withdrawal in 0.5%). Systemic effects were lightheadedness 1.7%, fluid retention 1.3%, tachycardia 0.9%, headache 0.4%, periorbital oedema 0.3% and insomnia 0.2%, leading to discontinuation in 1.2% of patients.

​
What happens when you stop

Topical minoxidil keeps hair follicles in the growing phase for longer while it is being applied. Once application stops, the follicles return to their normal cycle, and any regrowth gained during treatment is gradually lost, usually within several months. Long-term use is needed to maintain results.

​
Common questions

Visible change usually needs several months of regular use. Temporary increased shedding can occur early — this is normal and indicates the treatment is working. The doctor normally reviews tolerance and progress after several months.
Yes. Topical minoxidil combines well with finasteride or dutasteride. The two approaches work through different mechanisms — one on the follicle directly, the other on the hormone signal — and a doctor may recommend both together depending on your history.
Dryness, itching, flaking, redness or a burning sensation can occur, sometimes because of alcohol or propylene glycol in the solution. Using the foam formulation can reduce irritation. Stop and ask for advice if irritation is marked or persistent.
Yes. Accidental spread can cause unwanted facial or body hair. Wash hands after application and allow the scalp to dry fully. The 5% strength carries a warning against use in women because of this risk, so the 2% strength is used in women.
Oral minoxidil tablets are off-label for hair loss in the EU and carry a different safety profile. In a head-to-head trial, hypertrichosis occurred in 49% of people on oral versus 25% on topical, and headache in 14% versus 2%. The reviewing doctor discusses which form, if any, is appropriate for your case.

​
What has been reported (topical form)

Application-site reactions can occasionally be more severe and include peeling, blistering, bleeding or ulceration.
Oral minoxidil tablets are off-label for hair loss. EU-authorised minoxidil tablets are indicated only for severe resistant high blood pressure, and their product information states they must never be used alone or as initial therapy — always alongside a beta-blocker and a diuretic. That licensed dosing framework does not apply to the low doses used off-label for hair loss.

​
How to use it

Apply to a dry scalp, twice a day

Part the hair and spread 1 mL over the affected scalp, rather than the hair, and let it dry fully. Do not exceed 2 mL per day, regardless of area, unless your supplied product says otherwise.

Wash hands and avoid transfer

Keep the wet solution away from the face, broken skin, eyes, children, pets, pillows and other people. Do not use a hairdryer to speed drying.

Missed a dose?

Resume the next scheduled application. Do not apply extra solution.

Review after several months

Visible change usually needs several months of regular use. Review sooner if the scalp becomes persistently inflamed or whole-body symptoms develop.
Stop and seek prompt advice for chest pain, a fast heartbeat, faintness, sudden weight gain, or swelling of the hands or feet; a severe scalp reaction, facial swelling, or breathing difficulty; or if the pattern of hair loss becomes sudden, patchy, painful, inflamed, or remains unexplained.

​
How Hi-Doctor handles it

Our doctors review every hair-growth option and recommend what fits your history and goals. An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid at any EU pharmacy under Directive 2011/24/EU. See Propecia for the oral finasteride option it is often paired with, dutasteride for the DHT-blocker alternative, and oral minoxidil for the off-label tablet form. For the process, see how it works, and for pricing, see /essentials/pricing. For the full application guide, see the topical minoxidil guide on hi-doctor.ai. The safety page covers the full eligibility checks.

​
Start a consultation

Hair-growth consultation

Answer the hair-growth questionnaire and a registered doctor reviews it. They decide whether treatment is appropriate, which one, and at what dose — and declining is a normal outcome. See what it costs and how the review works.
This page is reference information, not medical advice and not a prescription. Whether a medicine is appropriate for you is decided by a registered doctor after reviewing your consultation.